Modeling the metabolic effects of terbutaline in β2‐adrenergic receptor diplotypes
暂无分享,去创建一个
William J Jusko | Niranjan Kissoon | N. Kissoon | Jianwei Wang | W. Jusko | J. Lima | John J Lima | Jianwei Wang | Nobuko Matsushima | James E Sylvester | N. Matsushima | James E. Sylvester
[1] R S Judson,et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Wheatley,et al. &bgr;2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans , 2000, Hypertension.
[3] L. Groop,et al. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. , 2001, Hypertension.
[4] S. Liggett,et al. Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling. , 2003, The Journal of biological chemistry.
[5] G. Dorn,et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. , 2000, Circulation research.
[6] J. Johnson,et al. Simple method for determination of terbutaline plasma concentration by high-performance liquid chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[7] Matthias Wjst,et al. Association of β2-Adrenoreceptor Variants with Bronchial Hyperresponsiveness , 2000 .
[8] R. Moore. Stimulation of Na:H exchange by insulin. , 1981, Biophysical journal.
[9] S. Liggett. Polymorphisms of the beta2-adrenergic receptor. , 2002, The New England journal of medicine.
[10] G. Corso,et al. Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. , 1980, The Journal of clinical endocrinology and metabolism.
[11] Y. Kawai,et al. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes. , 1986, The Journal of clinical endocrinology and metabolism.
[12] V. Large,et al. The different effects of a Gln27Glu β2‐adrenoceptor gene polymorphism on obesity in males and in females , 1999, Journal of internal medicine.
[13] E. Donahue,et al. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. , 1997, The Journal of clinical investigation.
[14] P. Matricardi,et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. , 1998, American journal of respiratory and critical care medicine.
[15] P. Cryer,et al. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.
[16] T. Waldron,et al. Quantitation of tremor in response to beta-adrenergic receptor stimulation in primates: relationship with hypokalemia. , 1998, Journal of pharmacological and toxicological methods.
[17] K. Nonogaki,et al. New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.
[18] Y. Kawai,et al. Adrenergic Receptors in Human Liver Plasma Membranes: Predominance of β2- and α1-Receptor Subtypes , 1986 .
[19] R. D. Lowrey. Modeling strategies , 1995 .
[20] L. Philipson. β-Agonists and metabolism , 2002 .
[21] C. Chu,et al. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog. , 2000, American journal of physiology. Endocrinology and metabolism.
[22] M. Kendall,et al. The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers. , 1993, British journal of clinical pharmacology.
[23] C. Chu,et al. The direct effects of catecholamines on hepatic glucose production occur via α1- and β2-receptors in the dog , 2000 .
[24] K. Alberti,et al. Regulation of glucose metabolism by norepinephrine in conscious dogs. , 1991, The American journal of physiology.
[25] R. Rizza,et al. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. , 1980, The Journal of clinical investigation.
[26] W J Jusko,et al. Physiologic indirect response models characterize diverse types of pharmacodynamic effects , 1994, Clinical pharmacology and therapeutics.
[27] Jianwei Wang,et al. Determination of Human β2-Adrenoceptor Haplotypes by Denaturation Selective Amplification and Subtractive Genotyping , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[28] F Skrabal,et al. beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. , 1999, Hypertension.
[29] K. Yamada,et al. Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus (Short Communication) , 1999, Diabetologia.
[30] R. Kim,et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. , 2001, The New England journal of medicine.
[31] T. Clausen. Regulation of active Na+-K+ transport in skeletal muscle. , 1986, Physiological reviews.
[32] M. Wjst,et al. Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness. , 2000, American journal of respiratory and critical care medicine.
[33] S. Liggett,et al. beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. , 2000, American heart journal.
[34] L C Gatewood,et al. Model studies of blood-glucose regulation. , 1965, The Bulletin of mathematical biophysics.
[35] P. Cryer,et al. Glycemic Actions of Alanine and Terbutaline in IDDM , 1993, Diabetes Care.
[36] R. Rizza,et al. Differential effects of epinephrine on glucose production and disposal in man. , 1979, The American journal of physiology.
[37] N. Harris,et al. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. , 2003, Diabetes.
[38] A. Koyanagi,et al. Polymorphism in the 5'-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[39] S. Liggett,et al. Hierarchy of Polymorphic Variation and Desensitization Permutations Relative to β1- and β2-Adrenergic Receptor Signaling* , 2003, The Journal of Biological Chemistry.
[40] T D Weir,et al. beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. , 1998, American journal of respiratory and critical care medicine.